The IMID Forum

Chief of the Allergy Immunology and Rheumatology Division and Executive Committee Member of the Center for Musculoskeletal Research. In this podcast, Prof Chris Ritchlin discusses how he became involved in rheumatology. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Professor Georg Schett from the University of Erlangen-Nuremberg. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Georg Schett discusses SARS-CoV-2 seroconversion in patients with immune-mediated inflammatory diseases receiving cytokine inhibitors.

Prof Iain McInnes discusses the long term safety of tofacitinib in PsA and drug retention. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed in this podcast is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Past president of EULAR, incoming president of ILAR and the Associate Editor of the Journal of Clinical and Experimental Rheumatology. In this podcast, Prof Maurizio Cutolo discusses circadian rhythms in inflammation alongside Prof Kevin Winthrop from Oregon Health and Science University. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Kennedy Professor of Translational Rheumatology at the Universities of Birmingham and Oxford. In this podcast, Prof Chris Buckley discusses his contribution to A-TAP for which he received the prestigious Carol Nachman prize in 2020. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Professor Axel Finckh from the Universirty of Geneva. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Axel Finckh discusses drug maintenacne in the Swiss population.

Professor Gerd Burmester from the Charité. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Gerd Burmester discusses the safety of tofacitinib in PsA and evaluates Hep B in baricitinib trials.

Dr Stanley Cohen from Southwestern Medical School. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Dr Stanley Cohen discusses a phase 2 trial of BTK inhibitor, fenebrutinib.

Prof Iain McInnes discusses the safety profile and temporary interruption of baricitinib. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed in this podcast is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Gain insight into the latest research presented at EULAR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition focuses on the safety of JAK inhibitors and features presentations from; Professor Leonard Calabrese, Professor Kevin Winthrop, Professor Iain McInnes and Professor Anja Strangfeld.